Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Exercise, hormones, and body temperature. Regulation and action of GH during exercise

    That physical exercise stimulates pituitary GH secretion has been known for forty years, but the underlying mechanisms as well as the physiological significance remain elusive. We have previously shown that th...

    Dr. J. O. L. Jørgensen, M. Krag, J. Kanaley in Journal of Endocrinological Investigation (2003)

  2. No Access

    Article

    The effect of the somatostatin analogue lanreotide on the prevention of urethral strictures in a rabbit model

    We evaluated the effect of the somatostatin analogue lanreotide on the development of surgically induced experimental strictures in the anterior urethra of the male rabbit. A total of 74 male rabbits were rand...

    H. L. Andersen, B. U. Duch, H. Gregersen, J. B. Nielsen, H. Ørskov in Urological Research (2003)

  3. Article

    Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia

    Non-islet cell tumour hypoglycaemia (NICTH) is characterised by severe and recurrent fasting hypoglycaemia, and is usually caused by secretion of insulin-like growth factor-II (IGF-II) by the tumour. This ind...

    J. Frystyk, C. Skjærbæk, J. Zapf, H. Ørskov in Diabetologia (1998)

  4. Article

    Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats

    Treatment of diabetic rats with octreotide can inhibit early diabetic renal hypertrophy. Octreotide administration for 6 months from the day of diabetes induction inhibits renal hypertrophy and diminishes incr...

    Dr. H. GrØnbÆk, B. Nielsen, R. Østerby, A. Harris, H. Ørskov, A. Flyvbjerg in Diabetologia (1995)

  5. Article

    Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats

    The insulin-like growth factors, insulin-like growth factor I and insulin-like growth factor II are bound to six distinct classes of insulin-like growth factor binding proteins (IGFBPs) in the circulation and ...

    A. Flyvbjerg, U. Kessler, B. Dorka, B. Funk, H. Ørskov, W. Kiess in Diabetologia (1992)

  6. Article

    Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes niellitus in rats

    Initial diabetic renal hypertrophy is preceded by a transient increase in kidney insulin-like growth factor I suggesting that insulin-like growth factor I may be implicated in diabetic kidney growth. The prese...

    A. Flyvbjerg, K. E. Bornfeldt, H. Ørskov, H. J. Arnqvist in Diabetologia (1991)

  7. Article

    Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat

    We have measured specific binding of insulin-like growth factor I and growth hormone to renal plasma membranes from control, streptozotocin-diabetic, insulin-treated diabetic, uninephrectomised and combined di...

    Dr. S. M. Marshall, A. Flyvbjerg, J. Frystyk, L. Korsgaard, H. Ørskov in Diabetologia (1991)

  8. No Access

    Article

    Reduction in sella turcica volume

    Ten patients with acromegaly were treated with the long-acting somatostatin analogue, Sandostatin (SMS 201-995, octreotide) for more than one year. Computerized tomography was performed before and on 4 differe...

    E. Lund, J. Jørgensen, S. E. Christensen, J. Weeke, H. Ørskov in Neuroradiology (1991)

  9. Article

    Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats

    It has recently been demonstrated that immunoassayable kidney insulin-like growth factor I concentration increases 24–48 h after induction of diabetes, preceding the initial renal hypertrophy. To elucidate whe...

    A. Flyvbjerg, K. E. Bornfeldt, S. M. Marshall, H. J. Arnqvist, H. Ørskov in Diabetologia (1990)

  10. Article

    Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats

    In a previous study we demonstrated that the kidney content of somatomedin C was maximal one to two days after uninephrectomy or induction of diabetes, and that insulin treatment prevented an increase in kidne...

    A. Flyvbjerg, J. Frystyk, O. Thorlacius-Ussing, H. Ørskov in Diabetologia (1989)

  11. Article

    96 DOSE-RESPONSE STUDIES WITH BIOSYNTHETIC HUMAN GROWTH HORMONE IN GROWTH HORMONE DEFICIENT PATIENTS

    Increasing doses of biosynthetic human growth hormone (B-hGH) were given subcutaneously to 7 GH deficient subjects for three 14 days periods (2, 4 and 6 IU/day at 20.00 h) followed by 14 days without GH therap...

    J O L Jørgensen, A Flyvjerg, T Lauritzen, H Ørskov, J S Christiansen in Pediatric Research (1988)

  12. Article

    41 EVIDENCE THAT POTASSIUM DEFICIENCY INDUCES GROWTH RETARDATION THROUGH REDUCED SOMATOMEDIN C PRODUCTION

    Growth retardation and impaired protein synthesis are major characteristics in potassium (K) depletion in animals and man. After K-repletion serum and muscle contents of K are normalized within few hours, whil...

    A Flyvbjerg, I Dørup, M E Everts, T Clausen, H Ørskov in Pediatric Research (1988)

  13. Article

    Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomised rats

    Kidney growth after induction of experimental diabetes in rats was compared to compensatory renal growth in response to unilateral nephrectomy. After 4 days of diabetes, kidney weight had increased from 816±21...

    A. Flyvbjerg, O. Thorlacius-Ussing, R. Næraa, J. Ingerslev, H. Ørskov in Diabetologia (1988)

  14. Article

    FERTILITY AND SEMEN QUALITY IN PREVIOUSLY GROWTH HORMONE TREATED MEN

    32 men aged 20-35 years (median 27.3 years) who were treated in childhood or adolescence with growth hormone participated in the study. Sixteen had isolated growth hormone deficiency and 16 panhypopituitarism ...

    S A Pedersen, J O Jørgensen, J S Christiansen, H Ørskov in Pediatric Research (1988)

  15. Article

    GROWTH HORMONE SECRETION AFTER CLONIDINE STIMULATION TEST IN PREVIOUSLY TREATED GROWTH HORMONE DEFICIENT CHILDREN

    Thrirty-four previously growth hormone treated persons aged 17 to 35 years, diagnosed in childhood as growth hormone deficient with insulin hypoglycaemia and growth hormone peak concentrations <7 ng/ml, were r...

    S A Pedersen, J O Jørgensen, J S Christiansen, H Ørskov in Pediatric Research (1988)

  16. Article

    THE METABOLIC CLEARANCE RATE, APPARENT DISTRIBUTION SPACE AND PLASMA HALF-LIFE OF UNLABELLEO BIOSYNTHETIC HUMAN GROWTH HORMONE IN HYPOPITUITARY PATIENTS

    Previously published information on GH metabolism in GH-deficient patients is scarce and data are conflicting. We studied the metabolic clearance rate (MCR), plasma half-life (T1/2) and apparent distribution spac...

    T Lauritzen, Jol Jørgensen, A Flyvbjerg, Js Christiansen, H ørskov in Pediatric Research (1988)

  17. Article

    EVIDENCE OF LOCAL DEGRADATION OF SUBCUTANEOUSLY INJECTED BIOSYNTHETIC HUMAN GROWTH HORMONE IN HYPOPITUITARY PATIENTS

    In a previous study we observed that subcutaneously (s.c.) injected human growth hormone (hGH) resulted in significantly lower serum growth hormone profiles (AUC) than after intramusculary (i.m.) administratio...

    Jol Jørgensen, Js Christiansen, A Flyvbjerg, T Lauritzen, H Ørskov in Pediatric Research (1988)

  18. Article

    A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clam**

    Two main methods are available for assessing insulin sensitivity with the hyperinsulinaemic euglycaemic clamp technique: one employs a glucose-controlled insulin infusion system (the Biostator) with automatic ...

    M. Ponchner, R. J. Heine, A. Pernet, I. Manning, A. J. Francis, D. Cook in Diabetologia (1984)

  19. No Access

    Article

    The metabolic effects of dopamine in man

    The metabolic effects of dopamine have been investigated by its infusion in normal man with and without simultaneous somatostatin administration. Dopamine was infused into overnight fasted men at 1.5 µg/kg/min (n

    A. Pernet, V. A. Hammond, G. Blesa-Malpica in European Journal of Clinical Pharmacology (1984)

  20. Article

    The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: Studies with a glucose controlled insulin infusion system (artificial endocrine pancreas)

    Twelve insulin deficient Type 1 (insulin-dependent) diabetic subjects were studied over an 11 1/2 h period during both subcutaneous insulin therapy and closed loop insulin delivery, using a glucose controlled ...

    R. Nosadini, G. A. Noy, M. Nattrass, K. G. M. M. Alberti, D. G. Johnston in Diabetologia (1982)

previous disabled Page of 2